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Résumé en
anglais
The use of stem cells in clinical trials started several years ago for regenerativebased
therapies or for the treatment of tumours. After brain injuries or neurodegenerative
diseases, neural stem cells represent a promising strategy to repair the affected tissue
and to replace degenerative cells. Neural stem cells can migrate and differentiate into
neurons, astrocytes and oligodendrocytes, and thus could serve as promising
therapeutic solutions. However, these cells can represent a potential source of cancer
stem cells in tumour brain where they are responsible of recurrence, invasiveness and
resistance to current treatments. Thus, few clinical trials involving endogenous,
genetically modifiedor derived-neural stem cells have been conducted in the world to
treat brain disorders. According to the website www.clinicaltrials.gov [10] only 37
clinical trials involving neural stem cells are listed. Most of them use derived-neural
stem cells to treat brain disorders (neurodegenerative diseases, injuries or tumours).
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